Evidence map›Paper›PMID 33927588›Full record

ArticleFrontiers in neuroscience2021

Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors.

Daniel J Torres, Jordan T Yorgason, Catherine C Mitchell, Ayaka Hagiwara, Marilou A Andres, Suguru Kurokawa, Scott C Steffensen, Frederick P Bellinger

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Daniel J TorresDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawai'i at Mânoa, Honolulu, HI, United States.
Jordan T YorgasonDepartment of Physiology and Developmental Biology, Brigham Young University, Provo, UT, United States.
Catherine C MitchellDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawai'i at Mânoa, Honolulu, HI, United States.
Ayaka HagiwaraDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawai'i at Mânoa, Honolulu, HI, United States.
Marilou A AndresPacific Biosciences Research Center, University of Hawai'i at Mânoa, Honolulu, HI, United States.
Suguru KurokawaFaculty of Pharmacy, Osaka Ohtani University, Osaka, Japan.
Scott C SteffensenDepartment of Psychology, Brigham Young University, Provo, UT, United States.
Frederick P BellingerDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawai'i at Mânoa, Honolulu, HI, United States.
University of Hawaiʻi at Mānoa · USBrigham Young University · USOsaka Ohtani University · JPUniversity of Hawaii System · US

Funding

Investigating sex-specific metabolic effects of disrupted selenocysteine lyase and selenocysteine tRNA in Agrp hypothalamic neuronsF32DK124963 · NIDDK · UNIVERSITY OF HAWAII AT MANOA · PI TORRES, DANIEL J. · 2020 to 2022
$206k
NIDDK NIH HHS F32 DK124963
6 · The paper itself

Abstract

Dopamine (DA) transmission plays a critical role in processing rewarding and pleasurable stimuli. Increased synaptic DA release in the nucleus accumbens (NAc) is a central component of the physiological effects of drugs of abuse. The essential trace element selenium mitigates methamphetamine-induced neurotoxicity. Selenium can also alter DA production and turnover. However, studies have not directly addressed the role of selenium in DA neurotransmission. Selenoprotein P (SELENOP1) requires selenium for synthesis and transports selenium to the brain, in addition to performing other functions. We investigated whether SELENOP1 directly impacts (1) DA signaling and (2) the dopaminergic response to methamphetamine. We used fast-scan cyclic voltammetry to investigate DA transmission and the response to methamphetamine in NAc slices from C57/BL6J SELENOP1 KO mice. Recordings from SELENOP1 KO mouse slices revealed reduced levels of evoked DA release and slower DA uptake rates. Methamphetamine caused a dramatic increase in vesicular DA release in SELENOP1 KO mice not observed in wild-type controls. This elevated response was attenuated by SELENOP1 application through a selenium-independent mechanism involving SELENOP1-apolipoprotein E receptor 2 (ApoER2) interaction to promote dopamine D2 receptor (D2R) function. In wild-type mice, increased vesicular DA release in response to methamphetamine was revealed by blocking D2R activation, indicating that the receptor suppresses the methamphetamine-induced vesicular increase. Our data provide evidence of a direct physiological role for SELENOP1 in the dopaminergic response to methamphetamine and suggest a signaling role for the protein in DA transmission.

Indexed as

apolipoprotein E receptor 2dopaminefast-scan cyclic voltammetrymethamphetamineselenoprotein P

Identifiers

PMID33927588
PMCPMC8076559
OpenAlexW3154100995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.